Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cell Therapy in Diabetes

16.11.2006
The European JDRF Center for Beta Cell Therapy in Diabetes reports in the Proceedings of the National Academy of Sciences of the USA its results on cell transplantation in 22 patients with type 1 diabetes.

These patients had a history of failing insulin production since several years making them dependent on insulin injections; their blood glucose levels had remained difficult to control leading to diverse complications including episodes of hypoglycemia with risk for coma.

The Center’s study indicates the number of donor insulin-producing beta cells that need to be transplanted in order to restore the endogenous insulin production and stop the insulin injections, and to control blood sugar levels and avoid hypoglycemia. One year after transplantation, the injection-free recipients produce considerable amounts of insulin with a maximal capacity that represents one fourth of that in age-matched individuals without diabetes.

These data form a basis for cell therapy in diabetes. They serve as reference for subsequent work that optimizes the combination of beta cell therapy and immune modulating drugs. The goal is to reach a long-term metabolic normalization with minimal side effects of the treatment. The biologic characteristics of the successful grafts are also used as quality control criteria in the Center’s projects on large scale laboratory generation of insulin-producing cells, for example from stem cells.

... more about:
»Insulin »beta »insulin-producing

The JDRF Center for Beta Cell Therapy in Diabetes is an international consortium of basic and clinical departments that is led by professor Daniel Pipeleers of Brussels Free University-VUB. The objective of the Center is to develop strategies for prevention and treatment of diabetes. Its program specifically focuses on the protection, replacement and regeneration of the insulin-producing beta cells (info on www.betacelltherapy.org). The Center is supported by the Juvenile Diabetes Research Foundation (New York- www.jdrf.org) and by the 6th Framework Program of the European Union.

Jan Van Autreve | alfa
Further information:
http://www.betacelltherapy.org

Further reports about: Insulin beta insulin-producing

More articles from Life Sciences:

nachricht Navigational view of the brain thanks to powerful X-rays
18.10.2017 | Georgia Institute of Technology

nachricht Separating methane and CO2 will become more efficient
18.10.2017 | KU Leuven

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Osaka university researchers make the slipperiest surfaces adhesive

18.10.2017 | Materials Sciences

Space radiation won't stop NASA's human exploration

18.10.2017 | Physics and Astronomy

Los Alamos researchers and supercomputers help interpret the latest LIGO findings

18.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>